Analysis of risk factors for mild cognitive impairment based on word list memory test results and questionnaire responses in healthy Japanese individuals registered in an online database.
Masayo OgawaDaichi SoneKazushi MaruoHiroyuki ShimadaKeisuke SuzukiHiroshi WatanabeHiroshi MatsudaHidehiro MizusawaPublished in: PloS one (2018)
Although the development of effective therapeutic drugs and radical treatment options for dementia and Alzheimer's disease (AD) remains urgent, progress in recent clinical trials of AD drugs has been less than adequate. In order to advance the progress of clinical trials, it is necessary to establish more efficient methods of recruitment. In Japan, there are registration systems stratified by mild cognitive impairment and preclinical and clinical stages of early and advanced stage dementia, but there is no registration system for healthy individuals yet. Therefore, in the present study, we developed a large-scale, internet-based health registry to investigate factors associated with cognitive function among registered participants. A total of 1038 participants completed the initial questionnaire and word list memory test. Among these participants, 353 individuals completed a second questionnaire and memory test. Stepwise multiple regression analysis was performed using IBM SPSS version 23.0 for Windows at a statistical significance level of p<0.05. We found that mood, motivation, and a decreased ability to perform activities of daily living were significantly associated with cognitive function. The results of the present study suggest that maintaining social involvement is important to prevent decreases in physical activity, daily function, mood, and motivation.
Keyphrases
- mild cognitive impairment
- cognitive decline
- clinical trial
- physical activity
- psychometric properties
- working memory
- healthcare
- cross sectional
- bipolar disorder
- mental health
- emergency department
- stem cells
- health information
- body mass index
- social media
- mesenchymal stem cells
- phase ii
- drug induced
- bone marrow
- climate change
- phase iii